Nearly 1 in 3 Patients Stop SGLT2 Inhibitors Within a Year
Original Article: https://www.medscape.com/viewarticle/nearly-1-3-stop-sglt2-inhibitors-within-year-real-world-2026a10011ob
The StudySodium-glucose cotransporter-2 (SGLT2) inhibitors are medications used to treat type 2 diabetes. In addition to lowering blood sugar, these drugs can help protect the heart and kidneys in certain patients. However, their benefits depend partly … [Read More]

